Oral Pathology and Oral Radiology, Faculty of Medicine, University of Turku, Turku, Finland.
Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Box 41, FI-00014, Helsinki, Finland.
Clin Oral Investig. 2023 Feb;27(2):625-630. doi: 10.1007/s00784-022-04762-w. Epub 2022 Oct 29.
Our goal was to study inflammatory bowel disease (IBD) patients' risk of head and neck squamous cell carcinoma (HNSCC), compared to general population.
We performed a retrospective nationwide register-based study of Finnish individuals diagnosed with IBD between the years 1995 and 2015. The standardized incidence ratio (SIR) of HNSCC was calculated by comparing the cohort's complementary age-year-sex-person-year incidence to that of the whole Finnish population.
About 70,567 patients were diagnosed with IBD (Crohn's disease or ulcerative colitis). Later, 89 of them were diagnosed with HNSCC with mean time of 6.82 years. The incidence of HNSCC was increased in IBD patients compared to the Finnish population expectation (SIR 1.3, 95% CI 1.065-1.614, P = 0.062). When calculating Crohn's disease and ulcerative colitis separately as well as men and women separately, the incidence was particularly increased for men with Crohn's disease (SIR 1.951, 95% CI 1.216-2.935, P = 0.025).
An increased risk for HNSCC was found in men with Crohn's disease compared to the Finnish population expectations.
This study provides information that would improve follow-up protocols and treatment guidelines of IBD.
我们旨在研究炎症性肠病(IBD)患者发生头颈部鳞状细胞癌(HNSCC)的风险,与普通人群相比。
我们进行了一项回顾性全国基于登记的研究,纳入了 1995 年至 2015 年间被诊断为 IBD 的芬兰个体。通过比较队列的互补年龄-年份-性别-人-年发病率与芬兰总人口的发病率,计算了 HNSCC 的标准化发病比(SIR)。
约有 70567 名患者被诊断为 IBD(克罗恩病或溃疡性结肠炎)。随后,其中 89 名患者被诊断为 HNSCC,平均时间为 6.82 年。与芬兰人群预期相比,IBD 患者的 HNSCC 发病率增加(SIR 1.3,95%CI 1.065-1.614,P=0.062)。当分别计算克罗恩病和溃疡性结肠炎以及男性和女性的发病率时,克罗恩病男性的发病率尤其增加(SIR 1.951,95%CI 1.216-2.935,P=0.025)。
与芬兰人群预期相比,克罗恩病男性发生 HNSCC 的风险增加。
本研究提供了信息,将有助于改进 IBD 的随访方案和治疗指南。